Introducing the Atropos Evidence™ Agent–seamlessly integrating RWE into the clinical workflow.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button®
          • Alexandria®
          • Forge®
          • Atropos Evidence™ Agent
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Atropos Health Named to the 2026 New York Digital Health 100

Atropos Health Named to the 2026 New York Digital Health 100

by Julia Rudo | Feb 3, 2026 | News and Media, Press Release

Atropos Health has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in...
Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data

by Julia Rudo | Dec 11, 2025 | Publications

A poster titled, “Early identification of patients likely to benefit from paroxysmal nocturnal hemoglobinuria workup using machine learning on large-scale real-world data,” was presented at the American Society of Hematology (ASH) 67th Annual Meeting by authors...
Atropos Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups

Atropos Health Named to the 2025 CB Insights’ List of the 50 Most Promising Digital Health Startups

by Julia Rudo | Oct 21, 2025 | Press Release

Atropos Health has been named to the CB Insights seventh annual “Digital Health 50” list, which showcases the 50 most promising private digital health companies globally. The company, which pioneers translating real-world clinical data into personalized...
Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care

Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of Care

by Julia Rudo | Sep 12, 2025 | News and Media

A recent MedCity News article discussing the competitive clinical decision support market positions Atropos Health as a key player with a differentiated approach. Amid a landscape of companies focusing on synthesis of existing literature, Atropos Health is unique in...
Atropos Health, Novartis partner for earlier detection of rare blood disorder

Atropos Health, Novartis partner for earlier detection of rare blood disorder

by Julia Rudo | Aug 25, 2025 | News and Media

“Atropos Health announced a partnership with pharmaceutical giant Novartis, {beginning with an AI model} to help identify individuals with the rare disease paroxysmal nocturnal hemoglobinuria (PNH) who have not yet been diagnosed. PNH is a rare blood disorder of the...
« Older Entries
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button®

Alexandria®

Forge®

Atropos Evidence™ Agent

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}